| Application no. and date | 20196657.9 (espacenet) (Federated) (European Patent Register), 20170616 | | Patent/reg. no. and date | DK/EP 3795181, 20250806 | | Publication date | 20210324 | | Priority no. and date | US 201662351234 P, 20160616 | | EP pub. no. and date |
EP 3795181 20210324 | | Effective date | | | Applicant/owner | Adverum Biotechnologies, Inc., 100 Cardinal Way
Redwood City, CA 94063, US | | Applicant ref. no. | BB366658EPDK | | Inventor | BLUMENKRANZ, Mark, 100 Cardinal Way
Redwood City
California 94063, US,
GASMI, Mehdi, 100 Cardinal Way
Redwood City
California 94063, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 35/761 (2015.01) , A61K 48/00 (2006.01) , A61P 27/02 (2006.01) , C12N 15/09 (2006.01) | | Title | BEHANDLING AF AMD VED ANVENDELSE AF AAV2-VARIANT MED AFLIBERCEPT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
